Literature DB >> 9586849

Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory.

M J Mattila1, J Vanakoski, H Kalska, T Seppälä.   

Abstract

Zolpidem (Zol), an omega1-agonist, acts via GABA(A) receptors but may differ qualitatively from diazepam (Dz) and other benzodiazepines (BZDs). We conducted a placebo-controlled, randomized, double-blind, and crossover study to compare the psychomotor and cognitive effects of 15 mg Zol with those of 15 mg Dz, 30 mg oxazepam (Ox), 7.5 mg zopiclone (Zop), and ethanol (EOH; 0.65 + 0.35 g x kg(-1)) given to 12 subjects at 1-week intervals. Psychomotor tests (symbol digit substitution, simulated driving, flicker fusion, body sway) were done before and 1, 3.5, and 5 h after intake; immediate and delayed memory were measured between 1.5 and 3.5 h. The plasma concentrations of drugs were measured by gas chromatography and by radioreceptor assay (RRA). The mean values of EOH in blood at 1.5, 4, and 5.5 h were 0.82, 0.88, and 0.6 g x l(-1), and the mean values of RRA-assayed plasma Dz were 470, 330, and 210 microg x l(-1), respectively. The corresponding values of other hypnosedatives, in Dz equivalents (microg x l(-1)), were 550, 750, and 330 for Ox; 350, 270, and 70 for Zol; and 160, 210, and 70 for Zop. The standard RRA graph for Zol was significantly flatter than those for other hypnotics. Zol impaired coordinative, reactive, and cognitive skills at 1 and 3.5 h more clearly than the other agents did, the most sensitive performance (tracking) still being impaired by Zol at 5 h. Dz and Zop were less active than Zol objectively; subjective sedation after Dz and Zol was stronger than after Zop. Compared to placebo, all active agents tended to impair learning and memory, their decremental effects, in declining order, being Zol, Dz > EOH, Ox > Zop. During the delay, Dz and Zol caused similar losses of material that had been learned. When separating "true" delayed memory from immediate memory (attention important), Dz and Zol had equieffects on delayed memory and were more detrimental than Zop. When contrasting that against the impaired psychomotor performances, it is possible that 15 mg Zol impairs memory relatively less than 15 mg Dz does.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9586849     DOI: 10.1016/s0091-3057(97)00506-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

Review 1.  Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.

Authors:  Hervé Allain; Danièle Bentué-Ferrer; Elisabeth Polard; Yvette Akwa; Alain Patat
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  The effects of fall-risk-increasing drugs on postural control: a literature review.

Authors:  Maartje H de Groot; Jos P C M van Campen; Marije A Moek; Linda R Tulner; Jos H Beijnen; Claudine J C Lamoth
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 3.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

4.  Low Doses of Ethanol Enhance LTD-like Plasticity in Human Motor Cortex.

Authors:  Anna Fuhl; Florian Müller-Dahlhaus; Caroline Lücke; Stefan W Toennes; Ulf Ziemann
Journal:  Neuropsychopharmacology       Date:  2015-06-03       Impact factor: 7.853

5.  Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening.

Authors:  Patricia Murphy; Dinesh Kumar; Gary Zammit; Russell Rosenberg; Margaret Moline
Journal:  J Clin Sleep Med       Date:  2020-02-06       Impact factor: 4.062

6.  Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.

Authors:  Stephanie C Licata; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-30       Impact factor: 5.067

7.  Deleterious effects of a low amount of ethanol on LTP-like plasticity in human cortex.

Authors:  Caroline Lücke; Tonio Heidegger; Mirjam Röhner; Stefan W Toennes; Lucia Krivanekova; Florian Müller-Dahlhaus; Ulf Ziemann
Journal:  Neuropsychopharmacology       Date:  2014-01-02       Impact factor: 7.853

8.  Hospitalization as a turning point for sleep medication use in older adults: prospective cohort study.

Authors:  Anna Zisberg; Efrat Shadmi; Gary Sinoff; Nurit Gur-Yaish; Einav Srulovici; Tamar Shochat
Journal:  Drugs Aging       Date:  2012-07-01       Impact factor: 3.923

9.  Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.

Authors:  Julia Boyle; Philippe Danjou; Robert Alexander; Nicole Calder; Cynthia Gargano; Nancy Agrawal; Irong Fu; Jacqueline B McCrea; M Gail Murphy
Journal:  Br J Clin Pharmacol       Date:  2008-12-16       Impact factor: 4.335

10.  Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.

Authors:  Hervé Allain; Danièle Bentué-Ferrer; Antoine Tarral; Jean-Marc Gandon
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.